Novartis completes first trial of its H1N1 vaccine, says only single dose needed
04 September 2009
Katie McQue
Please Login to read the full article.
04 September 2009
Katie McQue
katie.mcque@informa.com
Novartis's adjuvanted pandemic H1N1 vaccine Celtura induces sufficient protection with one dose, says the company after completing its first pilot trial of the vaccine.
"The study suggests that while two doses seem to provide better protection, one dose of our adjuvanted Celtura vaccine...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Asia Beat: Rising China vaccines tide to lift all boats
- Intercell and GSK patch it up in pandemic flu vaccination trial
- US Capitol Capsule: With wish granted, Collins forges ahead with new translational science centre
- EMA guidance points up challenges to biosimilar interferon beta developers
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
